Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D'Incalci

Showing results (11-20 of 339) with videos related to

Pageof 34
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Cell signaling and cancer treatmentD Corda, M D'Incalci
Clinical Pharmacokinetics|June 1, 1995
Clinical pharmacokinetics of altretamineG Damia, M D'Incalci
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Podophyllotoxin derivativesM D'Incalci, S Garattini
Cytotechnology|November 13, 2008
Mechanisms of resistance to alkylating agentsG Damia, M D'Incalci
Cancer Treatment Reports|April 1, 1986
Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamineA Paolini, M D'Incalci
Cancer Chemotherapy and Pharmacology|January 1, 1984
Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicityT Colombo, M D'Incalci
Expert Opinion on Investigational Drugs|July 1, 1997
DNA minor groove binding ligands: a new class of anticancer agentsM D'Incalci, C Sessa
Biochemical and Biophysical Research Communications|September 30, 1988
Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo)C Mannironi, M D'Incalci
Current Drug Targets|September 16, 2010
Genetic instability influences drug response in cancer cellsG Damia, M D'Incalci
FEBS Letters|July 27, 1992
Apoptosis. Biochemical events and relevance to cancer chemotherapyS Sen, M D'Incalci
Pageof 34

Showing results (11-20 of 339) with videos related to

Sort By:
Pageof 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Cell signaling and cancer treatmentD Corda, M D'Incalci
Clinical Pharmacokinetics|June 1, 1995
Clinical pharmacokinetics of altretamineG Damia, M D'Incalci
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Podophyllotoxin derivativesM D'Incalci, S Garattini
Cytotechnology|November 13, 2008
Mechanisms of resistance to alkylating agentsG Damia, M D'Incalci
Cancer Treatment Reports|April 1, 1986
Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamineA Paolini, M D'Incalci
Cancer Chemotherapy and Pharmacology|January 1, 1984
Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicityT Colombo, M D'Incalci
Expert Opinion on Investigational Drugs|July 1, 1997
DNA minor groove binding ligands: a new class of anticancer agentsM D'Incalci, C Sessa
Biochemical and Biophysical Research Communications|September 30, 1988
Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo)C Mannironi, M D'Incalci
Current Drug Targets|September 16, 2010
Genetic instability influences drug response in cancer cellsG Damia, M D'Incalci
FEBS Letters|July 27, 1992
Apoptosis. Biochemical events and relevance to cancer chemotherapyS Sen, M D'Incalci
Pageof 34